IL6 and rheumatoid arthritis: Arachidonylglycerol, which mediates immunomodulatory effects and reduces proinflammatory markers such as C-reactive protein (CRP), interleukin 6 and 1β, and TNFα in RA [49–51], was 3.85-fold higher in iPSCs than in FLS.